Market movement
In 2024, hormones: cortisone, hydrocortisone, prednisone (dehydrocortisone) and prednisolone (dehydrohydrocortisone) trade exhibited slight decline, with global flows reaching $264,834,732 and a three-year compound annual growth rate of +4.1% (five-year: -1.1%). The all-time peak of $413,101,460 was recorded in 2013; the current level is 36% below that high-water mark.
Over the 30-year observation window (1995–2024), 59% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is strengthening (+7.7% acceleration).
The World Trade Flows Characterization classifies hormones: cortisone, hydrocortisone, prednisone (dehydrocortisone) and prednisolone (dehydrohydrocortisone) as "One-way trade" in the unclassified price segment, providing additional context for market positioning and competitive dynamics.
